Trial results published in the Lancet suggest the new appetite suppressing pill by pharmaceutical giant Eli Lilly worked best for patients with Type 2 diabetes, with two positive outcomes ...

Venezuela’s win over the Netherlands on Friday provided a reminder of how the sport used to be played—and how much pride the ...

Chennai, March 5 -- Highlights: ...

Weight-loss drug pioneer Novo Nordisk will invest €432 million in upgrading its Athlone plant to produce the tablet form of its Wegovy therapy. The company said the Irish tabletting facility would ...

Memopezil is at the center of a rapidly growing conversation about cognitive health in 2026, as consumer interest in brain support has reached an all-time high, with search volume for terms like ...

Liver-related side effects have led some analysts to question fenebrutinib’s prospects, even though the drug has now cleared Phase 3 studies in multiple forms of the disease.

Orforglipron, a new glucagon-like peptide-1 (GLP-1) receptor agonist pill, leads to greater glycaemic control and weight loss for patients with type 2 diabetes than oral semaglutide (Rybelsus), ...

It can be difficult finding a coffee subscription among a sea of choices. So, we've done the legwork and compiled this list ...

Choosing a contraceptive method is a deeply personal decision, yet it is often shrouded in myths and old wives' tales. In India, many women hesitate to use oral contraceptive pills due to fears of ...

Domestic violence awareness groups, telehealth organizations and nearly two dozen Democratic attorneys filed briefs Monday in ...

A growing body of preclinical research is converging on a provocative idea: that the mental health benefits of physical ...

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of ...